Clinical Trial Update: ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a peptide-based tumor-associated antigen vaccine for glioblastoma, a malignant glioma. The study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• ETAPA I Peptide-based Tumor Associated Antigen Vaccine

Snippet

Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Conditions: Glioma, Malignant | Phase 1 | Status: ACTIVE_NOT_RECRUITING